Laura Schirosi - Concepedia

Author

Laura Schirosi

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

L Schirosi, L. Schirosi, Laura Schirosi, Schirosi Laura

Publications

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Istituto Tumori Bari University of Modena and Reggio Emilia Azienda Ospedaliero-Universitaria di Modena Santa Maria Nuova Hospital

About

Laura Schirosi is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	440
2	Immunology	5	5	303
3	Cell Biology	3	3	58
4	Gastroenterology	1	1	25
5	Obstetrics	1	1	55

Laura Schirosi

Publications

925

Citations

H-Index

Page 1

	Year	Citations
Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFRα, PDGFRβ, and Met in Large-Cell Neuroendocrine Carcinoma of the Lung Giulio Rossi, Alberto Cavazza, Alessandro Marchioni, Journal of Clinical Oncology	2005	298
Pleuro-pulmonary Solitary Fibrous Tumors Laura Schirosi, Sylvie Lantuéjoul, Alberto Cavazza, The American Journal of Surgical Pathology Pleuro-pulmonary SftsMedicineSurgical PathologyImmunologyPathology	2008	123
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors Laura Schirosi, Nazarena Nannini, D. Nicoli, Annals of Oncology Tumor BiologyC-kit MutationsDifferent C-kit InhibitorsOncogenic AgentMedicine	2012	73
The role of fetal autopsy and placental examination in the causes of fetal death: a retrospective study of 132 cases of stillbirths Luca Reggiani Bonetti, Paolo Ferrari, Nicoletta Trani, Archives of Gynecology and Obstetrics Placental ExaminationMaternal ComplicationForensic MedicineFetal MedicineGynecology	2010	55
Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients Ivana Catacchio, Nicola Silvestris, Emanuela Scarpi, Translational Oncology	2019	46
Impressive Response With Imatinib in a Heavily Pretreated Patient With Metastatic <i>c-KIT</i> Mutated Thymic Carcinoma Sebastiano Buti, Maddalena Donini, Pietro Sergio, Journal of Clinical Oncology Heavily Pretreated PatientMedicineImmunologyPathologyImmune Checkpoint Inhibitor	2011	45
Microsatellite and EGFR, HER2 and K-RAS Analyses in Sclerosing Hemangioma of the Lung Giuliana Sartori, Stefania Bettelli, Laura Schirosi, The American Journal of Surgical Pathology Sclerosing HemangiomaMedicineMultiple Pulmonary NoduleImmunologyUncommon Pulmonary Tumor	2007	37
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients? Laura Schirosi, Sabino Strippoli, Francesca Di Gaudio, BMC Cancer	2016	32
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz’s nevi but do not predict their biological behaviour Anna Maria Cesinaro, Laura Schirosi, Stefania Bettelli, Histopathology	2010	29
Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non–Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases Anna Scattone, Annamaria Catino, Laura Schirosi, Translational Oncology	2018	29

Page 1